AAMI
Acadian Asset Management
AAMI offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BAC
Bank of America Corporation
BAC has the edge over AAMI overall, supported by stronger valuation and stronger fundamentals.
AAMI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
AAMI's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like AAMI.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AAMI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.2x | $10.93 | -89% |
| Fair | 10x | $35.36 | -63% |
| Forward | 16x | $95.12 | — |
| Expensive | 19x | $64.47 | -32% |
| Current | 28x | $95.12 | — |
Historical ranges are pointers, not guarantees.
AAMI's PE is in its expensive range at 28x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over AAMI in the historical PE scenario, which offers more potential upside but is not a forecast.
AAMI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for AAMI, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AAMI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.90 | +73% |
| Q3 2026 | $3.41 | +45% |
| Q2 2026 | $2.83 | +19% |
| Q1 2026 | $2.35 | -1.7% |
| Q4 2025 | $2.21 | -0.5% |
| Q3 2025 | $2.35 | +42% |
| Q2 2025 | $2.38 | +43% |
| Q1 2025 | $2.39 | +46% |
| Q4 2024 | $2.22 | +43% |
AAMI's earnings per share have fallen from their peak: $3.41 over the past year, against $11.93 in late 2021.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
AAMI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $191.2M | +33% |
| Q2 2026 | $185.1M | +45% |
| Q1 2026 | $167M | +39% |
| Q4 2025 | $172.2M | +2.6% |
| Q3 2025 | $144.2M | +17% |
| Q2 2025 | $127.4M | +17% |
| Q1 2025 | $119.9M | +13% |
| Q4 2024 | $167.8M | +28% |
AAMI has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +8 points |
| Q2 2026 | 18% | +4.8 points |
| Q1 2026 | 25% | -1.5 points |
| Q4 2025 | 33% | -5.4 points |
| Q3 2025 | 18% | -3.5 points |
| Q2 2025 | 13% | -6.2 points |
| Q1 2025 | 27% | +4.9 points |
| Q4 2024 | 39% | +12 points |
AAMI's operating margin was 26% last quarter, up 8 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AAMI on profitability, with a higher operating margin.
AAMI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.3M | +$81.2M |
| Q2 2026 | $26M | -58% |
| Q1 2026 | -$44.9M | +$3.9M |
| Q4 2025 | $8.7M | +$27.8M |
| Q3 2025 | -$23.9M | -134% |
| Q2 2025 | $61.6M | +35% |
| Q1 2025 | -$48.8M | -$8.4M |
| Q4 2024 | -$19.1M | -145% |
AAMI's free cash flow was $47M over the past year, against −$30M the year before. Free cash flow isn't a meaningful measure for financial services companies like AAMI.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AAMI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -124K shares |
| 1 year | -0.7% | -247K shares |
| 3 years | -16% | -7M shares |
| 5 years | -57% | -47.6M shares |
| Available history | -59% | -50.3M shares |
AAMI has 36M diluted shares, down 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | — |
| Q1 2023 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | $103.2M |
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AAMI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AAMI Net Leverage
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AAMI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.2 | Neutral |
| Stochastic | 51.9 | Neutral |
AAMI's weekly RSI is 68 (neutral) and its Stochastic is 52 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AAMI PE vs Financial Services Sector
| Metric | AAMI | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 114% above |
| PE % | 92 | 63 | 29 pts above |
AAMI is trading at 28x earnings, a 114% premium to the Financial Services sector's median of 13x.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over AAMI on valuation relative to its sector.
AAMI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $92.7 | 2.7% above |
| 20 week MA | $89.6 | 6.2% above |
| 50 week MA | $71.2 | 34% above |
| 100 week MA | $53.1 | 79% above |
| 200 week MA | $37.8 | 152% above |
AAMI has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AAMI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.1 | $19.0 | +88% |
| 2021 | $19.0 | $25.7 | +35% |
| 2022 | $25.7 | $19.3 | -25% |
| 2023 | $19.3 | $19.2 | -0.8% |
| 2024 | $19.2 | $26.9 | +40% |
| 2025 | $26.9 | $48.4 | +80% |
| 2026 YTD | $48.4 | $95.1 | +97% |
AAMI has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.